Pew Prescription Project

Pew seeks to ensure transparency in physician-industry relationships and promotes policies to reduce or manage conflicts of interest that could affect patient care.

Patients benefit when physicians and researchers collaborate with the private sector to advance the development of effective new drugs and medical devices. However, there is widespread concern that extensive financial relationships between providers and industry, particularly payments associated with product promotion, may unduly influence the care that patients receive.

Such conflicts of interest threaten the integrity of scientific investigations, the objectivity of professional education, the quality of patient care, and the public’s trust in medicine.Institute of Medicine

Direct marketing by the pharmaceutical industry to medical professionals is estimated at $20 to $57 billion each year. A national survey published in the Archives of Internal Medicine found that 84 percent of doctors have some type of financial relationship with the pharmaceutical industry.

Pew’s work in this area seeks to ensure transparency in physician-industry relationships and promotes policies to reduce or manage conflicts of interest that could affect patient care. Our efforts have supported the creation of new policies at medical schools, professional medical associations, and have successfully supported state and federal disclosure laws.

Our Work

View All
  • What Is Your Doctor Getting Paid?

    The Physician Payments Sunshine Act requires that financial relationships between physicians and industry be made public on a government website known as Open Payments. Read More

  • Transparency and the Physician Payments Sunshine Act

    The pharmaceutical industry spent approximately $27 billion in 2012 promoting and marketing its products to physicians. These payments, and those made by the medical device industry, create medical conflicts of interest, which, according to the Institute of Medicine, “threaten the integrity of scientific investigations, the objectivity of professional education, the quality of patient care,... Read More

  • Pew Comments to FDA on Proposed Changes to Sunshine Act Reporting

    On September 2, Pew submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to proposed regulations which would change reporting under the Physician Payment Sunshine Act. Pew supports the elimination of the continuing medical education exclusion, and urges CMS to implement the Sunshine Act in the best interest of consumers. Read More

Media Contact

Sarah Carroll

Associate, Communications

202.540.6714